Pleural Mesothelioma: Advances in Blood and Pleural Biomarkers
Pleural mesothelioma (PM) is a type of cancer that is highly related to exposure to asbestos fibers. It shows aggressive behavior, and the current therapeutic approaches are usually insufficient to change the poor prognosis. Moreover, apart from staging and histological classification, there are no...
Main Authors: | Claudio Sorino, Michele Mondoni, Giampietro Marchetti, Sergio Agati, Riccardo Inchingolo, Federico Mei, Sara Flamini, Filippo Lococo, David Feller-Kopman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/22/7006 |
Similar Items
-
Identification of Highly Sensitive Pleural Effusion Protein Biomarkers for Malignant Pleural Mesothelioma by Affinity-Based Quantitative Proteomics
by: Nicolai B. Palstrøm, et al.
Published: (2023-01-01) -
Assessment of the value of mesothelin in differentiating between different pleural malignancies by different interventional modalities
by: Mona M Ahmed, et al.
Published: (2022-01-01) -
Circulating biomarkers in malignant pleural mesothelioma
by: Giuseppe Viscardi, et al.
Published: (2020-12-01) -
Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas
by: Sriram Krishna B, et al.
Published: (2012-09-01) -
Malignant pleural mesothelioma
by: Rao Sukhesh
Published: (2009-01-01)